Divgi et al. have carried out a prospective, open-label pilot study—the first of its kind—to determine whether iodine-124-labelled antibody chimeric G250 (124 I-cG250) and PET can accurately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results